Fortrea Reports Significant Goodwill Impairment and Lower 2026 Revenue Guidance
summarizeSummary
Fortrea Holdings Inc. reported a substantial GAAP net loss for 2025 due to a significant goodwill impairment and issued 2026 revenue guidance below 2025 actuals, despite strong Q4 book-to-bill.
check_boxKey Events
-
Full-Year 2025 Results
Reported GAAP net loss of $(986.2) million, or $(10.81) per diluted share, primarily due to a $797.9 million goodwill impairment charge. Revenue was $2,723.4 million.
-
2026 Financial Guidance
Issued revenue guidance in the range of $2,550 million to $2,650 million, which is lower than the 2025 actual revenue. Adjusted EBITDA guidance is $190 million to $220 million.
-
Goodwill Impairment
Recognized a significant non-cash goodwill impairment charge of $797.9 million in the first half of 2025, impacting full-year GAAP net loss.
-
Book-to-Bill Ratio
Achieved a strong 1.14x book-to-bill ratio for Q4 2025, with a trailing 12-month ratio of 1.02x, indicating new business wins.
auto_awesomeAnalysis
The filing reveals a challenging financial picture for Fortrea, primarily driven by a massive $797.9 million non-cash goodwill impairment charge in the first half of 2025, which led to a significant GAAP net loss. This impairment suggests a re-evaluation of the company's asset values. Furthermore, the 2026 revenue guidance of $2.55 billion to $2.65 billion is notably lower than the $2.72 billion reported for 2025, indicating an expected contraction in top-line performance. While the company achieved a strong 1.14x book-to-bill ratio in Q4 2025 and improved adjusted net income, the combination of the large impairment and reduced forward revenue outlook presents a negative signal for investors. The market will likely focus on the implications of the goodwill write-down and the path to renewed revenue growth.
At the time of this filing, FTRE was trading at $9.90 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $955.4M. The 52-week trading range was $3.97 to $18.67. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.